Arzeda
Arzeda designs novel proteins and enzymes using AI-driven computational methods, delivering BioSolutions for industries such as food and nutrition, home and personal care, advanced materials, and pharmaceuticals. Its products aim to improve customer products and manufacturing processes while reducing environmental impact.
Facts
- HQ
- Seattle, WA, US
- Sectors
- Biotechnology Research
- Founded
- 2009 Seattle business license
- Type
- Corporation Seattle business license
- Employees
- 79
- Registered name
- Arzeda Corp Seattle business license
- Members see funding amounts. .
- Founders
- Alexandre Zanghellini, David Baker
Is this your organization? Claim it
TerraPower Isotopes’ Chris Dunckley Leads Team Extracting Ultra-Rare Actinium-225 from Cold War Waste for Cancer Therapy
Chris Dunckley, director of chemistry and engineering at TerraPower Isotopes, leads a multidisciplinary team extracting the ultra-rare radioisotope actinium-225 from Cold War nuclear waste to develop promising cancer therapies. His leadership and scientific expertise help transform radioactive weapons waste into potentially life-saving medical treatments.
Seattle Startup Arzeda Raises $38M to Advance Protein Design for Industrial and Agricultural Applications
Seattle-based protein design startup Arzeda raised $38 million in its latest funding round, bringing total investments to $86 million to develop enzymes for industrial and agricultural uses. The company works with major partners like Unilever, BP, and Gore-Tex makers, and was the first spinout from the University of Washington's Institute for Protein Design.
University of Washington Launches Vilya with $50 Million to Develop Membrane-Permeable Peptide Drugs
University of Washington researchers developed custom peptides that penetrate cell membranes, enabling a new class of drugs with combined benefits of small molecules and protein therapeutics. They founded Vilya, backed by $50 million from Arch Venture Partners, to commercialize this drug platform described in Cell.
By Arzeda
See all 35Arzeda tells National Security Commission U.S. biotech lacks domestic manufacturing, risking commercial scale‑up to overseas partners
Arzeda, a Seattle enzyme-design startup that reaches about 1.8 billion consumers, says U.S. biotech companies have strong science but lack domestic manufacturing capacity and workforce, forcing them to rely on Western Europe and India; the National Security Commission on Emerging Biotechnology visited to hear calls for investment and infrastructure to keep production stateside.
MANE secures exclusive global license from Arzeda to produce and commercialize ViaLeaf™ Reb M, enabling end-to-end Reb M value chain
MANE secured an exclusive global license from Arzeda to produce and commercialize ViaLeaf™ Reb M, combining Arzeda’s AI-driven protein design with MANE’s manufacturing and commercial capabilities to scale a cost-effective, high-quality sugar-reduction ingredient worldwide.
Arzeda and KENT Specialty Milling Forge Product Development Agreement to Combine AI Protein Design with Manufacturing Scale
Arzeda and KENT Specialty Milling have entered a product development agreement to combine Arzeda’s AI-driven Intelligent Protein Design Technology with KENT’s manufacturing scale and market expertise to develop customer-focused protein solutions. The partnership aims to design and validate novel proteins to improve performance and efficiency across relevant end markets, though technical details and milestones remain undisclosed.
People
See all 5-
Alex Zanghelini Co-founder
-
Alexandre Zanghellini Executive Officer, Director, Promoter, Co-founder and PhD — Co-Founder & Chief Executive Officer
-
Ken Barrett Executive, MBA, MS — Chief Business Officer
Online
Questions about Arzeda
What is Arzeda?
Arzeda is a startup based in Seattle, WA, US that uses AI-driven computational methods to design proteins and enzymes. It delivers BioSolutions for food and nutrition, home and personal care, advanced materials, and pharmaceuticals.
What has Arzeda been in the news for?
GeekWire reported in September 2024 on Arzeda’s work to advance protein design for industrial and agricultural applications.
Who are the people behind Arzeda?
Alexandre Zanghellini is Arzeda’s co-founder and chief executive officer, and Alex Zanghelini is listed as a co-founder. Ken Barrett is chief business officer, and Sanjay Pal is chief financial officer.
Who invested in Arzeda, and how much has it raised?
Members of Seattle Flow see Arzeda's funding rounds, amounts and investors on its Funding tab. Joining is free.
Where is Arzeda based?
Arzeda is based in Seattle, WA, US.
When was Arzeda founded?
Arzeda was founded in 2009.